Traditional nonsteroidal anti-inflammatory drugs and postmenopausal hormone therapy: a drug-drug interaction?
<h4>Background</h4>Suppression of prostacyclin (PGI2) is implicated in the cardiovascular hazard from inhibitors of cyclooxygenase (COX)-2. Furthermore, estrogen confers atheroprotection via COX-2-dependent PGI2 in mice, raising the possibility that COX inhibitors may undermine the cardi...
Main Authors: | Luis Alberto García Rodríguez, Karine Egan, Garret A FitzGerald |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2007-05-01
|
Series: | PLoS Medicine |
Online Access: | https://doi.org/10.1371/journal.pmed.0040157 |
Similar Items
-
Nonsteroidal anti-inflammatory drugs in therapy for osteoarthrosis
by: V. V. Badokin
Published: (2009-03-01) -
Nonsteroid anti-inflammatory drugs
by: Wiliam Habib Chahade, et al.
Published: (2008-03-01) -
Nonsteroidal Anti-Inflammatory Drugs
Published: (2017) -
Nonsteroidal anti-inflammatory drugs in the epoch of biological therapy
by: A E Karateev, et al.
Published: (2008-09-01) -
Nonsteroidal Anti-Inflammatory Drugs and the Kidney
by: Walter H. Hörl
Published: (2010-07-01)